Home › Compare › EMITF vs GBDC

EMITF vs GBDC: Dividend Comparison 2026

EMITF yields 111.11% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $14.78M in total portfolio value· pulled ahead in Year 9
10 years
EMITF
EMITF
● Live price
111.11%
Share price
$1.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.07M
Annual income
$2,192,447.17
Full EMITF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — EMITF vs GBDC

📍 GBDC pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMITFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMITF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMITF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMITF
Annual income on $10K today (after 15% tax)
$9,444.44/yr
After 10yr DRIP, annual income (after tax)
$1,863,580.09/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $12,119,543.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMITF + GBDC for your $10,000?

EMITF: 50%GBDC: 50%
100% GBDC50/50100% EMITF
Portfolio after 10yr
$13.46M
Annual income
$9,321,590.50/yr
Blended yield
69.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

EMITF
No analyst data
Altman Z
-0.0
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMITF buys
0
GBDC buys
0
No recent congressional trades found for EMITF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMITFGBDC
Forward yield111.11% ✓11.86%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$6.07M$20.85M ✓
Annual income after 10y$2,192,447.17$16,450,733.83 ✓
Total dividends collected$5.48M$20.43M ✓
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: EMITF vs GBDC ($10,000, DRIP)

YearEMITF PortfolioEMITF Income/yrGBDC PortfolioGBDC Income/yrGap
1$21,811$11,111.11$12,492$1,791.70+$9.3K → EMITF
2$45,987$22,649.13$16,527$3,160.58+$29.5K → EMITF
3$93,836$44,629.82$23,588$5,904.90+$70.2K → EMITF
4$185,513$85,108.97$37,141$11,901.65+$148.4K → EMITF
5$355,752$157,252.56$66,205$26,463.38+$289.5K → EMITF
6$662,484$281,829.11$137,452$66,612.65+$525.0K → EMITF
7$1,199,347$490,489.82$342,372$195,298.53+$857.0K → EMITF
8$2,113,183$829,881.38$1,053,292$686,954.33+$1.06M → EMITF
9← crossover$3,627,652$1,366,546.40$4,111,439$2,984,416.95$483.8K → GBDC
10$6,074,035$2,192,447.17$20,849,974$16,450,733.83$14.78M → GBDC

EMITF vs GBDC: Complete Analysis 2026

EMITF — Stock

Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Full EMITF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this EMITF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMITF vs SCHDEMITF vs JEPIEMITF vs OEMITF vs KOEMITF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.